VC firms
Altitude Life Science Ventures is a venture capital firm based in Kirkland, WA that invests in early stage life science companies
Overview
Investment Type
Venture Capital
Investment Stage
Pre-Seed; Seed; Series A
Portfolio 31
| Date | Name | Website | Total Raised | Location |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Apr 21, 2022 | Ansa Biotechnologies, Inc. | ansabio.com | $131.6M | United States |
| Gossamer Bio | gossamerbio.com | $706M | United States, California, San Diego | |
| MILLENDO THERAPEUTICS | millendo.com | $92M | United States, Michigan, Ann Arbor | |
| Pulmatrix Inc. | pulmatrix.com | $19.7M | United States, Massachusetts, Lexington | |
| Omniome | omniome.com | $120M | United States, California, San Diego | |
| eFFECTOR Therapeutics, Inc. | effector.com | $123.6M | United States, California, San Diego | |
| UNITY Biotechnology | unitybiotechnology.com | $206M | United States, California, South San Francisco | |
| Nuvation Bio | nuvationbio.com | $275M | United States, New York | |
| Vividion Therapeutics | vividion.com | $317M | United States, California, San Francisco |
Show more
Mentions in press and media 7
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 9, 2025 | Ansa Biotechnologies: $54.4 Million Series B Raised To Transform DNA Synthesis | Ansa Biotechnologies, an emerging leader in the field of DNA synthesis, has announced the closing of a $45.2 million funding round. This financing also includes additional commitments totaling $9.2 million, positioning it as an oversubscrib... |
| Oct 2, 2025 | Ansa Biotechnologies Raises $54.4M in Series B Financing | Ansa Biotechnologies, an Emeryville, CA-based DNA synthesis company, raised $54.4M in Series B funding. The round was led by Cerberus Ventures with participation from Blue Water Life Science Advisors, Altitude Life Science Ventures, Fall Li... |
| Apr 15, 2025 | Northern Gritstone: Fueling the Future of Life Sciences and DeepTech in the North of England | In the heart of the North of England, a financial powerhouse is emerging. Northern Gritstone, an investment firm rooted in the rich soil of academia, has just secured a significant £50 million in funding. This is not just a number; it’s a b... |
| Apr 14, 2025 | Northern Gritstone: £50 Million Funding Raised To Invest In Life Sciences Companies | Northern Gritstone is a deep-tech and life sciences investment firm founded with the support of the Universities of Sheffield, Leeds, and Manchester. The firm has announced its latest fundraise of £50 million from leading institutional inve... |
| Apr 10, 2025 | Investment firm Northern Gritstone secures €58 million for life sciences and DeepTech | Manchester-based Northern Gritstone, the life sciences and DeepTech investment firm, has announced its latest fundraise of €58 million from leading institutional investors bringing its total permanent capital to €422 million. €40 million of... |
| Mar 21, 2018 | Term Sheet — Wednesday, March 21 | 5 Qs WITH A DEALMAKER Pär-Jörgen Pärson, a general partner at Swedish growth investment firm Northzone, made a really great bet 10 years ago. He led Spotify’s Series A round in 2008. Paid Content You can't secure what you can't see From Ext... |
Reviews 0
FAQ about Altitude Life Science Ventures
How many startups has Altitude Life Science Ventures invested in?
Altitude Life Science Ventures has 31 portfolio companies on Parsers VC, among them Ansa Biotechnologies, Inc., Gossamer Bio and MILLENDO THERAPEUTICS.
What has the press written about Altitude Life Science Ventures?
Parsers VC has collected 7 articles mentioning Altitude Life Science Ventures, among them “Ansa Biotechnologies: $54.4 Million Series B Raised To Transform DNA Synthesis” (Oct 9, 2025) and “Ansa Biotechnologies Raises $54.4M in Series B Financing” (Oct 2, 2025).
Is Altitude Life Science Ventures still active?
Yes, Altitude Life Science Ventures is active; its latest activity on Parsers VC dates from Oct 9, 2025.